What is the average price target for SURROZEN INC (SRZN) stock?
10 analysts have analysed SRZN and the average price target is 39.53 USD. This implies a price increase of 40.56% is expected in the next year compared to the current price of 28.12.
SURROZEN INC (SRZN) Forecast, Price Target & Analyst Ratings
NASDAQ:SRZN • US86889P2083
Current stock price
28.12 USD
-2.51 (-8.19%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SURROZEN INC (SRZN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 8, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.24
- Revenue Estimate
- 4.074M
Price Target Details & History
Consensus Price Target and Range
Mean target
$39.53
Upside
+ 40.56%
From current price of $28.12 to mean target of $39.53, Based on 10 analyst forecasts
Low
$36.36
Median
$39.27
High
$44.10
Price Target Revisions
1 Month
-7.74%
3 Months
4.73%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for SRZN. The average price target is 39.53 USD. This implies a price increase of 40.56% is expected in the next year compared to the current price of 28.12.
The average price target has been revised upward by 4.73% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.00%
SRZN was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SRZN.
In the previous month the buy percentage consensus was at a similar level.
SRZN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-21 | TD Cowen | Initiate | Buy |
| 2026-03-24 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2026-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-02-19 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-01-03 | Guggenheim | Upgrade | Neutral -> Buy |
| 2022-11-29 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-11-18 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-11-17 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2022-10-17 | JP Morgan | Initiate | Neutral |
| 2022-05-27 | B of A Securities | Downgrade | Buy -> Neutral |
| 2021-10-11 | B of A Securities | Initiate | Buy |
| 2021-09-15 | Guggenheim | Initiate | Buy |
| 2021-09-07 | Stifel | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 8, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$1.24
- Revenue Estimate
- 4.074M
- Revenue Q2Q
- N/A
- EPS Q2Q
- 83.29%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
1,118.95%
Revenue (3 Months)
N/A
EPS (1 Month)
6.59%
EPS (3 Months)
3.75%
Next Earnings Summary
SRZN is expected to report earnings on 5/8/2026. The consensus EPS estimate for the next earnings is -1.24 USD and the consensus revenue estimate is 4.07M USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 10.655M | 3.477M -67.37% | 6.097M 75.35% | 1.337M -78.07% | 1.337M | 1.337M | 6.107M 356.77% | 25.477M 317.18% | 48.181M 89.12% | 126.05M 161.62% | |
| EBITDA YoY % growth | -40.817M 3.69% | -24.097M 40.96% | -41.555M -72.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -42.728M 3.64% | -25.539M 40.23% | -42.092M -64.81% | -54.801M -30.19% | -75.424M -37.63% | -85.541M -13.41% | -111.918M -30.84% | -138.716M -23.94% | -146.008M -5.26% | -104.415M 28.49% | -51.875M 50.32% | |
| Operating Margin | N/A | -239.69% | -1,210.58% | -898.82% | -5,641.25% | -6,397.96% | -8,370.84% | -2,271.42% | -573.10% | -216.71% | -41.15% | |
| EPS YoY % growth | -21.36 -36.92% | -15.32 28.28% | N/A 37.58% | -4.24 55.71% | -3.45 18.60% | -3.47 -0.59% | -5.21 -50.29% | -5.36 -2.74% | -3.81 28.76% | -1.47 61.50% | 0.94 163.89% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.24 83.29% | -1.50 -159.00% | -1.43 82.92% | -0.96 21.00% | -0.83 33.47% | -0.91 39.66% | -1.00 30.00% | -1.09 -14.13% |
| Revenue Q2Q % growth | 4.074M | 674.22K -31.41% | 674.22K -31.41% | 674.22K 27.69% | 1.003M -75.38% | 1.003M 48.76% | 1.003M 48.76% | 1.003M 48.76% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.163M -6.41% | -14.304M -58.64% | -15.289M -40.46% | -16.609M -31.41% | -19.147M -88.40% | -20.825M -45.59% | -22.654M -48.17% | -24.648M -48.40% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.08%
EPS Next 5 Year
10.66%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-36.00%
Revenue Next 5 Year
-23.49%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SURROZEN INC / SRZN Forecast FAQ
When does SURROZEN INC (SRZN) report earnings?
SURROZEN INC (SRZN) will report earnings on 2026-05-08.
What are the consensus estimates for SRZN stock next earnings?
The consensus EPS estimate for the next earnings of SURROZEN INC (SRZN) is -1.24 USD and the consensus revenue estimate is 4.07M USD.
What is the number of analysts for SRZN stock?
The number of analysts covering SURROZEN INC (SRZN) is 10.